Mastering Triglyceride Science: An In-Depth Master's Course- SUMMER

Thank You for Joining Us!

Please complete the following evaluation to claim your credit for The Lipid Panel webcast presented on May 29, 2024.
1.Please Complete the following(Required.)
2.What is your area of specialization?
3.How long have you been in practice?
4.How many patients with dyslipidemia do you currently see each week?
5.Please mark your response to the following questions:
After participating in this activity, I am able to:
(Required.)
1- Strongly Disagree
2- Disagree
3- Neutral
4- Agree
5- Strongly Agree
Discuss strategies for the management of patients with lipid disorders.
Recognize the prevalence of triglyceride-rich remnant lipoproteins in ASCVD.
Discuss treatment options for hypertriglyceridemia, both for primary and secondary prevention of cardiovascular events in patients with ASCVD.
Outline appropriate therapy options for high CVD risk patients with elevated triglyceride levels.
Identify the clinical and genetic attributes, available diagnostic tools, and screening practices to aid the identification of individuals with chylomicronemia syndrome.
Explain the role of genetic testing in the identification of familial chylomicronemia syndrome (FCS) and multifactorial chylomicronemia (MCM).
Outline appropriate therapy options for patients with chylomicronemia syndrome and multifactorial chylomicronemia.
Discuss strategies to improve the knowledge, skills, or performance of the healthcare team.
6.Please mark your response to the following questions:
Rate your level of agreement with the statement(s) below:
(Required.)
1- Strongly Disagree
2- Disagree
3- Neutral
4- Agree
5- Strongly Agree
My opportunity for learning assessment was appropriate to the activity.
The content presented enhanced my current knowledge base.
The content presented was scientifically rigorous and evidence-based.
The scope, depth, and level of content were appropriate.
The invitation accurately conveyed the purpose and content.
The activities (e.g. faculty questions/discussion, case studies) provided appropriate and effective opportunities for active learning.
The activity promoted improvements of quality in health care.
7.Was this activity fair and balanced?(Required.)
8.Did the activity avoid commercial bias or influence?(Required.)
9.The faculty provided a disclosure and disclosed any off-label/investigational use of products discussed before the start of the activity.(Required.)
10.As a result of participating in this activity, what will you do differently to improve the care of your patients?
11.Select the one option below that most applies with this statement: Based upon my participation in this activity, I:(Required.)
12.If you gained new strategies, skills, and/or information that you plan to implement into your practice, what types of changes do you plan to implement?
13.What barriers do you see to implementing these changes in your practice?
14.Please provide any additional comments related to the activity in the space below.
15.Please indicate the type of credit you are claiming
(Required.)